{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Clover Health Investments Corp.
Is Clover Health Investments Corp. technically bullish or bearish?
As of October 24, 2025, Clover Health Investments Corp. shows a mildly bullish technical trend, supported by positive weekly MACD and Bollinger Bands, despite mixed signals from daily moving averages and KST, while outperforming the S&P 500 recently but underperforming over the longer term.
Clover Health Stock Soars 19.38%, Hits Intraday High of $3.92
Clover Health Investments Corp. has seen notable stock activity, with a significant intraday high. The company has outperformed the S&P 500 over various time frames, though its long-term fundamentals reveal challenges, including negative return on equity and ongoing losses, indicating a complex financial situation.
Clover Health Investments Corp. Opens with 5.0% Gain, Surging 19.37% in One Day
Clover Health Investments Corp. experienced a significant one-day stock performance, outperforming the S&P 500. Despite recent gains and a strong monthly rise, the company faces long-term challenges, including stagnant operating profit growth and a low average Return on Equity. Its market capitalization is around USD 1,456 million.
Is Clover Health Investments Corp. technically bullish or bearish?
As of October 24, 2025, Clover Health Investments Corp. shows a mildly bullish trend with positive momentum from MACD and Bollinger Bands, despite mixed signals from moving averages and performance lagging over the past year and five years.
Is Clover Health Investments Corp. technically bullish or bearish?
As of October 24, 2025, Clover Health Investments Corp. shows a mildly bullish trend supported by positive MACD and Bollinger Bands, despite some short-term caution from daily moving averages, while significantly outperforming the S&P 500 over the past week and month but lagging in longer-term performance.
Clover Health Investments Corp. Experiences Revision in Stock Evaluation Amid Market Challenges
Clover Health Investments Corp. has experienced a challenging year, with a significant decline in stock performance compared to the S&P 500. Recent evaluations show mixed technical indicators, reflecting ongoing struggles in the insurance sector. The company's long-term performance also reveals a substantial drop over the past five years.
Is Clover Health Investments Corp. technically bullish or bearish?
As of October 3, 2025, Clover Health Investments Corp. is in a bearish trend with mixed signals, having underperformed the S&P 500 significantly, with a year-to-date return of -16.83% compared to the S&P's 14.18%.
Is Clover Health Investments Corp. technically bullish or bearish?
As of October 3, 2025, Clover Health Investments Corp. is in a bearish trend with mixed indicators, having underperformed the S&P 500 significantly with a 1-year return of -35.25% compared to its 17.82% gain.
Is Clover Health Investments Corp. technically bullish or bearish?
As of October 3, 2025, Clover Health Investments Corp. has shifted to a bearish trend, indicated by negative signals from moving averages and Bollinger Bands, alongside a significant underperformance compared to the S&P 500.
Clover Health Investments Corp. Sees Revision in Stock Evaluation Amid Market Dynamics
Clover Health Investments Corp. has recently revised its evaluation amid changing market dynamics. The stock has shown fluctuations, with a notable return of 11.50% over the past year. Recent trends indicate a potential recovery phase, despite a challenging five-year performance and mixed technical indicators.
Clover Health Stock Soars 8.33%, Hits Intraday High of $3.34
Clover Health Investments Corp., a small-cap insurance company, experienced a notable stock movement on September 23, 2025. Year-to-date, it has outperformed the S&P 500, with significant profit growth. However, challenges remain, including a negative return on equity and no dividend yield, highlighting concerns about its long-term fundamentals.
Is Clover Health Investments Corp. technically bullish or bearish?
As of September 12, 2025, Clover Health Investments Corp. shows a mildly bearish trend, with daily moving averages and monthly indicators reflecting bearish sentiment, while underperforming the S&P 500 with a year-to-date return of -2.54% compared to the S&P's 12.22%.
Is Clover Health Investments Corp. overvalued or undervalued?
Clover Health Investments Corp. is considered overvalued and risky due to its high Price to Book Value of 4.80, negative ROE of -7.27%, and underperformance with a 1-year return of 2.33% compared to the S&P 500's 17.14%.
Clover Health Investments Corp. Sees Revision in Stock Evaluation Amid Mixed Performance Indicators
Clover Health Investments Corp. has recently seen a revision in its evaluation, reflecting changes in technical indicators. The company’s stock price is currently at $3.14, with a mixed performance compared to the S&P 500. Its recent weekly return has been strong, while year-to-date results remain slightly negative.
Is Clover Health Investments Corp. overvalued or undervalued?
Clover Health Investments Corp. has been downgraded to "risky" due to its overvaluation, reflected in a high Price to Book Value of 4.80, an EV to EBITDA ratio of 981.70, a negative Return on Equity of -7.27%, and recent underperformance against the S&P 500, with its stock price at 2.83.
Is Clover Health Investments Corp. technically bullish or bearish?
As of May 27, 2025, the trend has shifted to mildly bearish due to bearish signals from the weekly MACD, Bollinger Bands, and KST, despite some bullish indicators on the monthly scale.
What does Clover Health Investments Corp. do?
Clover Health Investments Corp. is a micro-cap insurance company with a market cap of approximately $1.49 billion, currently reporting a net loss and no dividend yield. Key metrics indicate negative profitability and high debt levels.
How big is Clover Health Investments Corp.?
As of Jun 18, Clover Health Investments Corp. has a market capitalization of $1.49 billion, with net sales of $0 million and a net profit of -$24.37 million. The company's balance sheet shows shareholder's funds of $341.14 million and total assets of $580.74 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
